Concepedia

Author

Anneliese Schneider

Roche (Switzerland)

Also Known As

A Schneider, A. Schneider, Anneliese Schneider

37

Publications

1K

Citations

14

H-Index

44

Concepts

All Affiliations

Roche (Switzerland)University of TübingenUniversity of BaselTechnical University of MunichRoche Pharma AG (Germany)
AS

About

Anneliese Schneider is an author at Roche (Switzerland) specializing in medicine, radiation oncology, and tumor biology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

6

6

449

2

Cell Biology

3

3

316

3

Natural Sciences

2

2

99

4

Biochemistry

2

2

99

5

Allergy

1

1

27

Anneliese Schneider

×

13

Publications

908

Citations

13

H-Index

YearCitations

The epithelial tumor antigen MUC1 is expressed in hematological malignancies and is recognized by MUC1-specific cytotoxic T-lymphocytes.

Peter Brossart, Anneliese Schneider, Patricia Dill,

PubMed

2001

201

Transforming growth factor‐beta 2 gene silencing with trabedersen (AP 12009) in pancreatic cancer

Karl‐Hermann Schlingensiepen, Frank Jaschinski, Sven Arke Lang,

Cancer Science

2011

139

Stable Expression of Human Cytochrome P450 1B1 in V79 Chinese Hamster Cells and Metabolically Catalyzed DNA Adduct Formation of Dibenzo[<i>a</i>,<i>l</i>]pyrene

Andreas Luch, Stephanie L. Coffing, Yong Tang,

Chemical Research in Toxicology

1998

111

Human immunocompetent Organ-on-Chip platforms allow safety profiling of tumor-targeted T-cell bispecific antibodies

S. Jordan Kerns, Chaitra Belgur, Debora B. Petropolis,

eLife

2021

69

Analysis of off-tumour toxicities of T-cell-engaging bispecific antibodies via donor-matched intestinal organoids and tumouroids

Marius F. Harter, Timothy Recaldin, Régine Gérard,

Nature Biomedical Engineering

2023

62

Small, Potent, and Selective Diaryl Phosphonate Inhibitors for Urokinase-Type Plasminogen Activator with In Vivo Antimetastatic Properties

Jurgen Joossens, Omar M. Ali, Ibrahim El Tantawy El Sayed,

Journal of Medicinal Chemistry

2007

53

Final results of a phase I/II study in patients with pancreatic cancer, malignant melanoma, and colorectal carcinoma with trabedersen.

Helmut Oettle, Thomas Seufferlein, Thomas A. Luger,

Journal of Clinical Oncology

2012

53

Quantification of Oligonucleotides by LC–MS/MS: The Challenges of Quantifying A Phosphorothioate Oligonucleotide and Multiple Metabolites

Matthew Ewles, Lee Goodwin, Anneliese Schneider,

Bioanalysis

2014

49

Stable Expression of Human Cytochrome P450 3A4 in Conjunction with Human NADPH-Cytochrome P450 Oxidoreductase in V79 Chinese Hamster Cells

Anneliese Schneider, Wolfgang A. Schmalix, S. Vasanthi,

Archives of Biochemistry and Biophysics

1996

46

Src/lck inhibitor dasatinib reversibly switches off cytokine release and T cell cytotoxicity following stimulation with T cell bispecific antibodies

Gabrielle Leclercq-Cohen, Hélène Haegel, Anneliese Schneider,

Journal for ImmunoTherapy of Cancer

2021

39

Page 1